These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8218292)

  • 1. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
    Olson ST; Francis AM; Sheffer R; Choay J
    Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
    Bock PE; Shore JD; Tans G; Griffin JH
    J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
    Page JD; You JL; Harris RB; Colman RW
    Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
    Thompson RE; Mandle R; Kaplan AP
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of heparin to human high molecular weight kininogen.
    Björk I; Olson ST; Sheffer RG; Shore JD
    Biochemistry; 1989 Feb; 28(3):1213-21. PubMed ID: 2713360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel procoagulant and anticoagulant pathways for high molecular weight kininogen coagulant function.
    Olson ST; Sheffer R; Shore JD
    Agents Actions Suppl; 1992; 38 ( Pt 1)():241-8. PubMed ID: 1466276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
    Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
    J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.
    Schapira M; Scott CF; Colman RW
    Biochemistry; 1981 May; 20(10):2738-43. PubMed ID: 6910423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of kallikrein in human plasma.
    van der Graaf F; Koedam JA; Bouma BN
    J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies.
    Hock J; Vogel R; Linke RP; Müller-Esterl W
    J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity.
    Yarovaya GA; Dotsenko VL; Orekhovich VN
    Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein.
    Kerbiriou DM; Bouma BN; Griffin JH
    J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.
    Weisel JW; Nagaswami C; Woodhead JL; DeLa Cadena RA; Page JD; Colman RW
    J Biol Chem; 1994 Apr; 269(13):10100-6. PubMed ID: 8144509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin.
    Lin Y; Pixley RA; Colman RW
    Biochemistry; 2000 May; 39(17):5104-10. PubMed ID: 10819977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage.
    Meloni FJ; Gustafson EJ; Schmaier AH
    Blood; 1992 Mar; 79(5):1233-44. PubMed ID: 1536948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.